DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Asia Pacific Wound Debridement Devices Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Asia-Pacific wound debridement devices market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing number of diabetes and related wounds, increasing geriatric population, increasing incidence of burn cases, increased awareness towards wound care management. On the other hand, high cost of advanced wound debridement products is restraining the market.

The Asia-Pacific wound debridement devices market is segmented based on product into five segments; hydrosurgical, low-frequency ultrasound, mechanical, larval therapy and others. In 2018, hydrosurgical segment is estimated to rule with the market with the highest market shares in 2025, rising at a specific CAGR. However, low-frequency ultrasound segment is growing at the highest CAGR in the forecast period of 2018 to 2025.

Mechanical method is further sub-segmented into monofilament fiber pad, gauze, paraffin tulle and wet-to-dry debridement. In 2018, monofilament fiber pad segment is estimated to rule with certain market shares and rising at the highest CAGR in the forecast period of 2018 to 2025.

The Asia-Pacific wound debridement devices market is segmented based on method into five segments; autolytic, enzymatic, surgical, mechanical and maggot. In 2018, autolytic segment is valued to rule with highest market shares and rising at the highest CAGR of in the forecast period of 2018 to 2025.

Based on wound type, the Asia-Pacific wound debridement devices market is segmented into surgical wound, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. In 2018, surgical wound segment is projected to rule with highest market shares and rising at a specific CAGR. However, diabetic ulcers segment is rising with the highest CAGR in the forecast period of 2018 to 2025.

Companies Mentioned

Advanced Medical Solutions Group PLC Advancis Medical UK Arobella Medical B. Braun Melsungen AG BioMonde BSN Medical Coloplast Group DeRoyal Industries Inc. Hollister Incorporated Integra LifeSciences Italia Medica Srl Lohmann & Rauscher GmbH Medtronic Misonix Mlnlycke Health Care AB Organogenesis Inc. Olympus Corporation Smith & Nephew Sring GmbH Zimmer Biomet

For more information about this report visit https://www.researchandmarkets.com/research/q833pt/asia_pacific?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005327/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Wound Care

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 06:56 AM/DISC: 08/23/2018 06:56 AM

http://www.businesswire.com/news/home/20180823005327/en